CRVO – cervomed inc. (US:NASDAQ)

News

CervoMed Inc. (NASDAQ: CRVO) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $55.00 price target on the stock.
CervoMed Announces Key Senior Leadership Appointments
CervoMed Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
CervoMed Awarded the Prix Galien USA 2024 Prize for Best Startup
CervoMed to Participate in Upcoming Investor Conferences
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com